PainReform Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	8.04	4.11	16.57	15.69	0.95	0.05
Short-Term Investments	0	6.09	0	0	0	0
Cash & Cash Equivalents	8.04	10.19	16.57	15.69	0.95	0.05
Cash Growth	-21.15%	-38.50%	5.62%	1556.81%	1958.70%	-
Other Current Assets	1.76	2.09	2.45	2.1	0.03	0.03
Total Current Assets	9.8	12.28	19.02	17.79	0.97	0.08
Property, Plant & Equipment	0.13	0.04	0.05	0.01	0	0
Other Long-Term Assets	0	0	0	0	0.19	0
Total Long-Term Assets	0.13	0.04	0.05	0.01	0.19	0
Total Assets	9.93	12.33	19.07	17.8	1.16	0.08
Accounts Payable	0.22	0.21	0.14	0.72	0.17	0.02
Current Debt	0.06	0	0	0	6.17	0
Other Current Liabilities	2.13	0.86	0.62	0.24	0	0
Total Current Liabilities	2.41	1.06	0.76	0.96	6.34	0.02
Long-Term Debt	0.03	0	0	0	0	4.52
Other Long-Term Liabilities	0.25	0.24	0.23	0.22	7.07	6.62
Total Long-Term Liabilities	0.28	0.24	0.23	0.22	7.07	11.14
Total Liabilities	2.69	1.31	0.99	1.18	13.41	11.16
Total Debt	0.09	0	0	0	6.17	4.52
Debt Growth	-	-	-	-	36.57%	-
Retained Earnings	-41.86	-32.52	-23.73	-16.48	-12.43	-11.15
Shareholders' Equity	7.24	11.02	18.08	16.62	-12.24	-11.08
Net Cash / Debt	7.95	10.19	16.57	15.69	-5.23	-4.47
Net Cash / Debt Growth	-21.99%	-38.50%	5.62%	-	-	-
Net Cash Per Share	6.07	9.42	16.58	48.37	-90.64	-77.60
Working Capital	7.39	11.22	18.26	16.83	-5.37	0.06
Book Value Per Share	5.53	10.19	18.09	51.23	-212.35	-192.14

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).